Neocarzinostatin, a clinical anticancer drug, is the archetypal member of the chromoprotein family of enediyne antitumor antibiotics that are composed of a nonprotein chromophore and an apoprotein. The neocarzinostatin chromophore consists of a nine-membered enediyne core, a deoxyaminosugar, and a naphthoic acid moiety. We have previously cloned and sequenced the neocarzinostatin biosynthetic gene cluster and proposed that the biosynthesis of the naphthoic acid moiety and its incorporation into the neocarzinostatin chromophore are catalyzed by five enzymes NcsB, NcsB1, NcsB2, NcsB3, and NcsB4. Here we report the biochemical characterization of NcsB1, unveiling that: (i) NcsB1 is an S-adenosyl-L-methionine-dependent O-methyltransferase; (ii) NcsB1 catalyzes regiospecific methylation at the 7-hydroxy group of its native substrate, 2,7-dihydroxy-5-methyl-1-naphthoic acid; (iii) NcsB1 also recognizes other dihydroxynaphthoic acids as substrates and catalyzes regiospecific O-methylation; and (iv) the carboxylate and its ortho-hydroxy groups of the substrate appear to be crucial for NcsB1 substrate recognition and binding, and O-methylation takes place only at the free hydroxy group of these dihydroxynaphthoic acids. These findings establish that NcsB1 catalyzes the third step in the biosynthesis of the naphthoic acid moiety of the neocarzinostatin chromophore and further support the early proposal for the biosynthesis of the naphthoic acid and its incorporation into the neocarzinostatin chromophore with free naphthoic acids serving as intermediates. NcsB1 represents another opportunity that can now be exploited to produce novel neocarzinostatin analogs by engineering neocarzinostatin biosynthesis or applying directed biosynthesis strategies.
Neocarzinostatin (NCS),3 a clinical anticancer drug used to treat leukemia and cancers of the bladder, stomach, pancreas, liver, and brain, is an archetypal member of the chromoprotein family of enediyene antitumor antibiotics that are composed of a nonprotein chromophore and an apoprotein (1-3). NCS was originally isolated from Streptomyces carzinostaticus in 1965 (1-3). Its apoprotein NcsA is encoded by the ncsA gene and protects, carries, and delivers the reactive NCS chromophore (4). The NCS chromophore (1, Fig. 1B) is composed of a ninemembered enediyne core, a deoxyaminosugar, and a naphthoic acid moiety (2, 5). As a member of the enediyne family, the biological activity of NCS is derived from its ability to cleave DNA (6). The NCS chromophore undergoes Myers-Saito cycloaromatization to form a 2,6-indacene diradical species that subsequently abstracts hydrogen atoms from the deoxyribose of DNA, leading to single-and double-stranded DNA breaks (2, 7). For NCS, a thiol is often required to trigger the cycloaromatization, although a few enediynes have been reported to form diradicals via the cycloaromatization in a thiol-independent manner, likely the result of the intrinsic reactivity of the nine-membered ring enediyne core (1, 2, 7). The mechanism of action for NCS also invo...